(Q46662065)

24 December 2017

title

Natural isoprenoids are able to reduce inflammation in a mouse model of mevalonate kinase deficiency (English)

1 reference

24 December 2017

0 references

6

1 reference

24 December 2017

Alessandro Ventura

7

1 reference

24 December 2017

author name string

Annalisa Marcuzzi

1

1 reference

24 December 2017

Alessandra Pontillo

2

1 reference

24 December 2017

Luigina De Leo

3

1 reference

24 December 2017

Alberto Tommasini

4

1 reference

24 December 2017

Giuliana Decorti

5

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 August 2008

1 reference

24 December 2017

published in

Pediatric Research

1 reference

24 December 2017

volume

64

1 reference

24 December 2017

issue

2

1 reference

24 December 2017

page(s)

177-182

1 reference

24 December 2017

Mevalonate kinase deficiency and autoinflammatory disorders

cites work

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181761870

Anakinra is safe and effective in controlling hyperimmunoglobulinaemia D syndrome-associated febrile crisis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181761870

Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181761870

Lack of isoprenoid products raises ex vivo interleukin-1beta secretion in hyperimmunoglobulinemia D and periodic fever syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181761870

Manipulation of isoprenoid biosynthesis as a possible therapeutic option in mevalonate kinase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181761870

Regulation of isoprenoid/cholesterol biosynthesis in cells from mevalonate kinase-deficient patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181761870

The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood gd T cells in response to aminobisphosphonates is inhibited by statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181761870

Modulation of TNF-alpha gene expression by IFN-gamma and pamidronate in murine macrophages: regulation by STAT1-dependent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181761870

Single-dose pharmacokinetics and tolerability of alendronate 35- and 70-milligram tablets in children and adolescents with osteogenesis imperfecta type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181761870

Stimulation of inflammatory responses in vitro and in vivo by lipophilic HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181761870

Mutual augmentation of the induction of the histamine-forming enzyme, histidine decarboxylase, between alendronate and immuno-stimulants (IL-1, TNF, and LPS), and its prevention by clodronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181761870

Inhibition of mevalonate pathway is involved in alendronate-induced cell growth inhibition, but not in cytokine secretion from macrophages in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181761870

The lack of non-steroid isoprenoids causes oxidative stress in patients with mevalonic aciduria

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181761870

Mevalonate kinase deficiency and autoinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181761870

Statin-induced proinflammatory response in mitogen-activated peripheral blood mononuclear cells through the activation of caspase-1 and IL-18 secretion in monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181761870

Farnesol and geraniol chemopreventive activities during the initial phases of hepatocarcinogenesis involve similar actions on cell proliferation and DNA damage, but distinct actions on apoptosis, plasma cholesterol and HMGCoA reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181761870

Geranylgeraniol and beta-ionone inhibit hepatic preneoplastic lesions, cell proliferation, total plasma cholesterol and DNA damage during the initial phases of hepatocarcinogenesis, but only the former inhibits NF-kappaB activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181761870

Exogenous farnesol interferes with the normal progression of cytokine expression during candidiasis in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181761870

The IL-1 receptor and Rho directly associate to drive cell activation in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181761870

Identification and functional characterization of a presqualene diphosphate phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181761870

Anti-inflammatory activity in vitro and in vivo of the protein farnesyltransferase inhibitor tipifarnib

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181761870

Deletion of a single mevalonate kinase (Mvk) allele yields a murine model of hyper-IgD syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181761870

10.1203/PDR.0B013E3181761870

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

Dimensions Publication ID

1013442336

0 references

1 reference

24 December 2017